Literature DB >> 15480092

Retinal microvascular changes and target organ damage in untreated essential hypertensives.

Cesare Cuspidi1, Stefano Meani, Maurizio Salerno, Veronica Fusi, Barbara Severgnini, Cristiana Valerio, Eleonora Catini, Arturo Esposito, Fabio Magrini, Alberto Zanchetti.   

Abstract

BACKGROUND AND
PURPOSE: The clinical and prognostic significance of initial retinal alterations in hypertensive patients remains controversial. Therefore, we assessed the relationship of microvascular abnormalities with prognostically validated markers of target organ damage (TOD), such as left ventricular mass (LVM), carotid intima-media thickness (IMT) and microalbuminuria, in early stages of untreated essential hypertension.
METHODS: A total of 437 consecutive, never-treated patients with grade 1 or 2 essential hypertension, referred to our outpatient clinic, underwent the following procedures: (1) clinical and routine laboratory examinations, (2) 24-h ambulatory blood pressure monitoring, (3) 24-h urine collection for microalbuminuria, (4) echocardiography, (5) carotid ultrasonography, (6) non-mydriatic retinography. Patients were divided into group I, with either a normal retinal pattern (n=65, 14.9%) or arteriolar narrowing (n=185, 42.4%) and group II with arteriovenous crossings (n=187, 42.7%).
RESULTS: The two groups were similar for gender, body mass index, smoking habit, heart rate, clinic and ambulatory blood pressure (BP) values, while mean age was slightly but significantly higher in group II than in group I (47.6 +/- 10.7 versus 44.5 +/- 12.5 years, P=0.008). No differences occurred between the two groups in LVM index (101.8 +/- 18.5 versus 99.9 +/- 20.4 g/m), carotid IMT (0.67 +/- 0.12 versus 0.66 +/- 0.20 mm), urinary albumin excretion rate (14.4 +/- 27.7 versus 13.3 +/- 27.7 mg/24 h) as well as in the prevalence of LV hypertrophy (14.3 versus 14.0%), IM thickening and/or plaques (26.5 versus 27.2%) (both defined according to 2003 ESH-ESC guidelines) and microalbuminuria (10.1 versus 8.7%). Furthermore, the three different retinal artery patterns were similarly distributed among tertiles of LV mass index, IMT and urinary albumin excretion rate.
CONCLUSIONS: These results show that: (1) a very large fraction (more than 80%) of untreated, recently diagnosed hypertensive patients have initial retinal microvascular abnormalities detectable by non-mydriatic retinography, (2) the presence of arteriovenous crossings is not associated with more prominent cardiac and extracardiac TOD, (3) fundoscopic examination has a limited clinical value to detect widespread organ involvement in early phases of grade 1 and 2 hypertension.

Entities:  

Mesh:

Year:  2004        PMID: 15480092     DOI: 10.1097/00004872-200411000-00010

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  16 in total

1.  Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA).

Authors:  Tien Yin Wong; F M Amirul Islam; Ronald Klein; Barbara E K Klein; Mary Frances Cotch; Cecilia Castro; A Richey Sharrett; Eyal Shahar
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

Review 2.  Hypertensive retinopathy revisited: some answers, more questions.

Authors:  A Grosso; F Veglio; M Porta; F M Grignolo; T Y Wong
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

3.  The association of severity of retinal vascular changes and cardiac remodelling in systemic hypertension.

Authors:  Mary Varghese; Srilakshmi M Adhyapak; Tinku Thomas; Meera Sunder; Kiron Varghese
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-02-14

4.  Factors associated with changes in retinal microcirculation after antihypertensive treatment.

Authors:  P R Antonio; P S Marta; D D J Luís; D P J Antonio; S T Manuel; M S Rafael; G V Sonia; G P Manuel; M-N Isabel; E N J Carlos; C T Gabriel; G U I Francisco
Journal:  J Hum Hypertens       Date:  2013-11-21       Impact factor: 3.012

5.  Target organ damage in hypertensive patients: correlation between retinal arteriovenular ratio and left ventricular geometric patterns.

Authors:  R Meazza; C Scardino; L Grosso Di Palma; G L Perrucci; E Gallazzi; M Cattaneo; A Villarini; F Magrini
Journal:  J Hum Hypertens       Date:  2013-08-01       Impact factor: 3.012

6.  Accuracy of retinal changes in predicting microalbuminuria among elderly hypertensive patients: a cross-sectional study from a teaching hospital in South India.

Authors:  Ghanshyam Palamaner Subash Shantha; Emmanuel Bhaskar; Anita A Kumar; Varun Sundaram; Arul Senghor; Porchelvan Swaminathan; Manjunath Sundaresan; Yadav Srinivasan; Georgi Abraham
Journal:  Int Urol Nephrol       Date:  2008-09-03       Impact factor: 2.370

7.  Measurement of retinal wall-to-lumen ratio by adaptive optics retinal camera: a clinical research.

Authors:  Eva Meixner; Georg Michelson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-08-13       Impact factor: 3.117

8.  Regression of alterations in retinal microcirculation following treatment for arterial hypertension.

Authors:  Antonio Pose-Reino; Marta Rodríguez-Fernández; Bashir Hayik; Francisco Gomez-Ulla; María José Carrera-Nouche; Francisco Gude-Sampedro; Juan Carlos Estévez-Nuñez; Isabel Méndez-Naya
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-08       Impact factor: 3.738

9.  Comparing the associations of clinic vs. ambulatory blood pressure with subclinical organ damage in young healthy adults: the African-PREDICT study.

Authors:  Dimoné Botha; Yolandi Breet; Aletta E Schutte
Journal:  Hypertens Res       Date:  2021-02-09       Impact factor: 3.872

10.  Relationship between target organ damage and blood pressure, retinal vessel calibre, oxidative stress and polymorphisms in VAV-2 and VAV-3 genes in patients with hypertension: a case-control study protocol (LOD-Hipertension).

Authors:  Manuel A Gomez-Marcos; Rogelio Gonzalez-Sarmiento; José I Recio-Rodríguez; Cristina Agudo-Conde; Luis Gamella-Pozuelo; Nuria Perretta-Tejedor; Carlos Martínez-Salgado; Luis García-Ortiz
Journal:  BMJ Open       Date:  2014-04-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.